APOBEC (Apolipoprotein B Editing Complex Like Polypeptide) cytidine deaminases normally serve to restrict retroelements (retroviruses and retrotransposons) by removing an amino group from cytidines in single stranded (ss) DNA formed during the retroelement's replication cycle. By accessing ssDNAs formed during replication, repair or transcription in chromosomes, APOBECs can cause mutations in human cancer genomes. So far, the APOBEC3B and APOBEC3A proteins are the main candidates for inducing mutation in human cancers, however other APOBECs from this subclass or even other APOBEC-like proteins also could be involved. The mutagenesis signature of these enzymes has been recently found in multiple types of human cancers [1][2][3]. The fraction of APOBEC signature mutations in a cancer exome can be as high as 70% of the entire mutation load and the number of such mutations can be over 1,000. These findings have led to the general question about presence of APOBEC mutagenesis pattern in various sequenced cancer genomes or exomes. Because of APOBECs' sequence- and ssDNA substrate-specificity, statistical analysis can be performed for a single defined mechanism-based hypothesis. This provides sufficient statistical power to highlight and evaluate the pattern within a complex mix of mutagenic processes operating throughout the history of individual cancers. Moreover, statistical evaluation can be done for each individual sample allowing the identification of individual tumors that contain significant presence of the APOBEC mutagenesis pattern, which in turn enables downstream exploration for correlations between this mutagenesis and tumor genotype and phenotype.
Components of the Pattern of Mutagenesis by APOBEC Cytidine Deaminases (P-MACD) analysis:
-
The genome- or exome-wide prevalence of the APOBEC mutagenesis signature and the enrichment of this signature over its presence expected for random mutagenesis. APOBECs deaminate cytidines predominantly in a tCw motif. The APOBEC mutagenesis signature is composed of approximately equal numbers of two kinds of changes in this motif – tCw→tTw and tCw→tGw mutations (flanking nucleotides shown in small letters; w=A or T). tCw→tAw changes are not included into P-MACD analysis, because cytosine deamination in ssDNA predominantly results in changes to thymine or guanine as compared to changes to adenine. P-MACD calculates on a per sample basis, the enrichment of the APOBEC mutation signature among all mutated cytosines in comparison to the fraction of cytosines that occur in the tCw motif among the +/- 20 nucleotides surrounding each mutated cytosine. In addition, P-MACD calculates other parameters that characterize the prevalence of the APOBEC mutagenesis pattern in a sample and/or that are useful for downstream analyses and comparisons. The results of the APOBEC mutagenesis signature analyses are presented on Figures 1–5.
-
The presence of C- or G-coordinated clusters of closely spaced mutations. C- or G-coordinated mutation clusters contain stretches of mutations, each separated by <10,000 nt, that either occur only at cytosines or only in guanines of the same strand within a given cluster. Moreover, the probability of producing the spatial distribution of mutations in these clusters by random distribution of all the mutations estimated to occur within the genome is < 1E-4. C- or G-coordinated clusters are enriched with APOBEC signature mutations. The presence of such clusters supports a mechanism of mutagenesis via cytidine-specific lesions in transient stretches of ssDNA. Cluster analysis works the best for whole-genome sequence (WGS) data, but can have sufficient statistical power to be utilized with whole-exome sequencing (WES). The results of cluster analysis are shown on Figures 6–9.
Both parts of analysis are described in detail in reference [3]
There are 289 tumor samples in this analysis. The Benjamini-Hochberg-corrected p-value for enrichment of the APOBEC mutation signature in 4 samples is <=0.05. Out of these, 2 have enrichment values >2, which implies that in such samples at least 50% of APOBEC signature mutations have been in fact made by APOBEC enzyme(s).
Column content and calculation of values referred in the legends to all figures below are described in “Readme_columns_in_sum_files.txt” file (see hyperlink in the Output section.)
-
Mutation Annotation File (MAF): tab-delimited table of tumor-specific mutation calls per row in The Cancer Genome Atlas (TCGA) format, based on either whole exome sequenciong (WES) or whole genome sequencing (WGS). Non-ASCII binary characters (>127 decimal) are not allowed in any column. The file is not required to be a TCGA MAF, however the following column names and the value syntax in these columns should be fixed:
-
Sample ID – column name: “Tumor_Sample_Barcode”, value syntax not defined, each sample ID must be unique;
-
Chromosome – column name: “Chromosome”; value syntax: 1-22, X, Y.
(Note that P-MACD filters out mutation calls for which chromosome name is not one of the 24 standard human chromosomes, such as mitochondrial DNA or unassigned chromosomal fragments.) -
Position – column name: “Start_position”; value syntax: integer numbers
-
Reference allele – column name: “Reference_Allele”; value syntax; A, T, C, G (nucleotides in capitals)
-
Tumor allele – column name: “Tumor_Seq_Allele2”; value syntax: A, T, C, G (nucleotides in capitals)
-
Variant type – column name: “Variant_Type”; value syntax: SNP (single base substitutions), other – not defined
-
Reference Genome: nucleotide sequence of the reference genome with one entry per chromosome in FASTA format.
-
Fraction of Genome Sequenced: 0.01 for whole-exome MAF and 1.0 for whole-genome MAF. (Used only to identify mutation clusters).
This run of P-MACD was executed with the following parameter values as inputs:
-
Mutation Annotation File = Mutsig_maf_modified.maf.txt
-
Reference Genome = /xchip/cga/reference/hg19/hg19canonical.fa
-
Fraction of Genome Sequenced = 0.01
A detailed description of the output files is provided in the Readme files:
-
“Readme_content_of_files.txt” file: provides a description of the content of each file in the output, identified by a content specific suffix following the name of the original MAF file.
-
“Readme_columns_in_anz_MAF_files.txt” file: describes the columns that P-MACD adds to the input MAF file.
-
“Readme_columns_in_sum_files.txt” file: describes the columns in all “*_sorted_sum*.txt” files.
-
“*_List_of_inputs.txt” file: provides the information about the MAF file and input values specific for a run and provided by the user;
There are two main parts of the output:
MAF files “*_sorted_anz*.txt”
which contain all columns of the initial MAF file with rows sorted by “Tumor_Sample_Barcode”, then by “Chromosome”, then by “Start_position”. P-MACD removes duplicate mutations if multiple rows exist that contain identical values within the “Tumor_Sample_Barcode”, “Chromosome”, “Start_position”, “Reference_Allele”, and “Variant_Type” columns. Duplicates occur when a single MAF contains mutations identified by comparing the sequence of one tumor sample to both whole blood and adjacent normal tissue controls. P-MACD retains the first occurrence of the duplicated mutation in the sorted MAF. The output MAFs contain also several additional columns annotating each mutation based on whether it fits the APOBEC mutation signature (columns: APOBEC_mutation, APOBEC_mutation_to_G, and APOBEC_mutation_to_T) and if it occurs in a cluster of tightly spaced mutations. Groups of very tightly spaced mutations with inter-mutation distances <10 nt, which are likely to arise from a mutagenesis event triggered by trans-lesion synthesis across a single DNA lesion, are also highlighted. Such events are called complex and counted as a single mutation when calculating cluster p-values. Annotating mutations by the APOBEC signature highlights mutations that were likely caused by APOBEC mutagenesis. Such separation should be done only in samples with a statistically significant fold enrichment and large effect size. For example, if a sample has a statistically significant 2-fold enrichment with the APOBEC mutagenesis pattern, then at least 50% of APOBEC signature mutations could be expected to be really caused by APOBEC cytidine deamination.
Summary files “*_sorted_sum*.txt”
There are two kinds of summary files:
A. Sample-specific summaries.
Each row in a summary file provides values calculated for a given sample. The last row provides totals among all samples. The summary files directly used for generating Figures 1–9 are listed in the legend(s) of the corresponding Figure(s). The following values (all present in “*_sorted_sum_all_fisher_Pcorr.txt” file) are the most useful for analyses investigating correlations between APOBEC mutagenesis and other features of cancer samples:
-
Fold-enrichment with APOBEC mutagenesis signature – “APOBEC_enrich” column;
-
Absolute number of APOBEC signature mutations in a sample – “tCw_to_G+tCw_to_T” column;
-
Fraction of APOBEC signature mutations in a sample – “[tCw_to_G+tCw_to_T]_per_mut” column;
-
Benjamini-Hochberg-corrected p-values – “BH_Fisher_p-value_tCw” column.
-
Minimum estimate of the number of APOBEC induced mutations in a sample – “APOBEC_MutLoad_MinEstimate” column
B. Summaries across all samples.
The file “*_sorted_sum_APOBECenrich_ClustSize.txt” contains results of calculations graphically represented in Figure 9.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.